These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31466865)

  • 1. The significance of ANCA positivity in patients with inflammatory bowel disease.
    Lee WI; Subramaniam K; Hawkins CA; Randall KL
    Pathology; 2019 Oct; 51(6):634-639. PubMed ID: 31466865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).
    Stinton LM; Bentow C; Mahler M; Norman GL; Eksteen B; Mason AL; Kaplan GG; Lindkvist B; Hirschfield GM; Milkiewicz P; Cheung A; Janssen HL; Fritzler MJ
    PLoS One; 2014; 9(11):e112877. PubMed ID: 25397578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Proteinase 3 Antibodies as a Biomarker for Ulcerative Colitis and Primary Sclerosing Cholangitis in Children.
    Laass MW; Ziesmann J; de Laffolie J; Röber N; Conrad K
    J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):463-470. PubMed ID: 35703948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-ANCA/proteinase 3-positive colitis in children: a distinctive form of inflammatory bowel disease or vasculitis with colitis as initial presentation?
    Van Biervliet S; Bonroy C; Vande Velde S; De Bruyne R; Van Winckel M; Peeters H; Delanghe J; Stove V; De Vos M
    J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):489-92. PubMed ID: 23752080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.
    Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL
    World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical indications of the use of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in the evaluation of inflammatory bowel disease at an Academic Medical Center.
    Gupta A; Derbes C; Sellin J
    Inflamm Bowel Dis; 2005 Oct; 11(10):898-902. PubMed ID: 16189419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
    Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value.
    Olives JP; Breton A; Hugot JP; Oksman F; Johannet C; Ghisolfi J; Navarro J; Cézard JP
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):142-8. PubMed ID: 9252899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
    Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
    Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of antibodies anti-saccharomyces cerevisiae (ASCA) and autoantibodies in patients with inflammatory bowel disease].
    Beltrão M; Bodas A; Azevedo F; Nunes A; Santos C; Delgado L
    Acta Med Port; 2010; 23(5):829-36. PubMed ID: 21144323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of serological assays in pediatric inflammatory bowel disorders.
    Mainardi E; Villanacci V; Bassotti G; Liserre B; Rossi E; Incardona P; Falchetti D; Tonegatti L; Montanelli A; Barabino A; Coccia C; Gambini C
    Digestion; 2007; 75(4):210-4. PubMed ID: 17952008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical, cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
    Frenzer A; Fierz W; Rundler E; Hammer B; Binek J
    J Gastroenterol Hepatol; 1998 Sep; 13(9):950-4. PubMed ID: 9794196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study.
    Mundwiler ML; Mei L; Landers CJ; Reveille JD; Targan S; Weisman MH
    Arthritis Res Ther; 2009; 11(6):R177. PubMed ID: 19930665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel diseases and Takayasu's arteritis: coincidence or association?
    Kilic L; Kalyoncu U; Karadag O; Akdogan A; Dogan I; Bilgen SA; Kiraz S; Ertenli I
    Int J Rheum Dis; 2016 Aug; 19(8):814-8. PubMed ID: 26913584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological markers in inflammatory bowel diseases.
    Reumaux D; Sendid B; Poulain D; Duthilleul P; Dewit O; Colombel JF
    Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):19-35. PubMed ID: 12617880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of perinuclear antineutrophil cytoplasmic antibodies in subjects with primary sclerosing cholangitis.
    Guglielmi V; Giorgio P; Guerra V; Sonnante A; Tutino M; Donghia R; Pisani A
    Minerva Med; 2022 Jun; 113(3):513-517. PubMed ID: 32407046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool.
    Montanelli A; Mainardi E; Vagni A; Villanacci V; Zambelli C; Cestari R; Cengia P; Minelli L; Missale G
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):201-7. PubMed ID: 15990710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis.
    Dobric S; Popovic D; Nikolic M; Andrejevic S; Spuran M; Bonaci-Nikolic B
    Clin Chem Lab Med; 2011 Nov; 50(3):503-9. PubMed ID: 22107137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders.
    Stoffel MP; Csernok E; Herzberg C; Johnson T; Carroll SF; Gross WL
    Clin Exp Immunol; 1996 Apr; 104(1):54-9. PubMed ID: 8603534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.